comparemela.com

Latest Breaking News On - Redalpine venture partners - Page 1 : comparemela.com

The movement to put the brakes on generative A I gains steam

Elon Musk, Steve Wozniak and more than 1,000 others are urging companies to hit pause.

La maisonUnited statesNew yorkFrance generalUnited kingdomSage hillCity ofWest palm beachEmad mostaqueJackson fordyceSteve wozniakConnor leahyBarryj glickJessica mathewsSam altmanElon musk

Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response

Through AI/ML-enabled platform with a biology-first approach, Genialis looks to propel drug development, diagnostics and treatment planning Genialis, a computational precision medicine company unraveling

United statesAndrea vuturoRafael rosengartenMiha stajdoharHamzeh abdulHealth venturesVuturo group for genialisDebiopharm innovation fundRegeneron pharmaceuticalsFirst star venturesRedalpine venture partnersHamzeh abdul hadiGeniali boardInvestment directorDebiopharm innovationClinical oncology

Debiopharm International SA: Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response

Debiopharm Innovatoin Fund & Taiwania Capital co-lead financing round for Genialis to propel drug development, diagnostics and treatment planning through AI/ML-enabled platform with a biology-first

Slovenia generalUnited statesHamzeh abdulRafael rosengartenMiha stajdoharAndrea vuturoHealth venturesRegeneron pharmaceuticalsDebiopharm innovatoin fund taiwania capitalVuturo group for genialisDebiopharm innovation fundHead of communicationsDebiopharm innovatoin fundTaiwania capitalFirst star venturesRedalpine venture partners

Genialis Raises $13M in Series A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United statesSlovenia generalRafael rosengartenHamzeh abdulMiha stajdoharHealth venturesDebiopharm innovatoin fundTaiwania capitalFirst star venturesRedalpine venture partnersHamzeh abdul hadiGeniali board

Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response

Genialis is developing next-generation patient classifiers using machine learning and high-throughput omics data…

Miha stajdoharRafael rosengartenOncologydescribing oncxernaHamzeh abdulHealth venturesDebiopharm innovation fundShould knowFirst star venturesRedalpine venture partnersHamzeh abdul hadiGeniali boardPlatform withInvestment directorDebiopharm innovationClinical oncologydescribing oncxerna

vimarsana © 2020. All Rights Reserved.